Challenges of artificial intelligence in precision oncology: public-private partnerships including national health agencies as an asset to make it happen-Reference-Cited by-同舟云学术

Challenges of artificial intelligence in precision oncology: public-private partnerships including national health agencies as an asset to make it happen

Published:2023-09 Issue: Volume: Page:
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Luu V.P.^ORCID,Fiorini M.,Combes S.,Quemeneur E.,Bonneville M.,Bousquet P.J.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference49 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021

2. New driver mutations in non-small-cell lung cancer;Pao;Lancet Oncol,2011

3. The emerging treatment landscape of targeted therapy in non-small-cell lung cancer;Yuan;Signal Transduct Target Ther,2019

4. Immune checkpoint inhibitors alone vs immune checkpoint inhibitors—combined chemotherapy for NSCLC patients with high PD-L1 expression: a network meta-analysis;Wang;Br J Cancer,2022

5. Next-generation diagnostics for precision oncology: preanalytical considerations, technical challenges, and available technologies;Walter;Semin Cancer Biol,2022

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Artificial Intelligence in Rhinology;Otolaryngologic Clinics of North America;2024-10

2. Enhancing risk management in hospitals: leveraging artificial intelligence for improved outcomes;Italian Journal of Medicine;2024-04-15

3. Novel and Proven Models of Public, Private, and Public–Private Partnerships in Healthcare: An Update;Handbook of Experimental Pharmacology;2024